SNB Capital Reduces Jamjoom Pharmaceuticals PT, Keeps at Neutral

MT Newswires · 2d ago
08:34 AM EDT, 08/20/2026 (MT Newswires) -- SNB Capital on Wednesday lowered its price target for pharmaceutical company Jamjoom Pharmaceuticals Factory (SASE:4015) to 153.10 Saudi riyals from 172 riyals, while maintaining a neutral rating. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)